Histatin-5 vs Pemvidutide
Head-to-head comparison of Histatin-5 (Human histatin 5) and Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | Pemvidutide |
|---|---|---|
| Category | Dental & Oral | Weight Management |
| Full Name | Human histatin 5 | Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist |
| Molecular Weight | 3035 Da | N/A |
| Half-Life | minutes in saliva | Approximately 1 week |
| Amino Acids | 24 | N/A |
| Typical Dose | 1-100 µM in research formulations | Trial-dependent; once-weekly SC titration |
| Route | Topical/Oral rinse | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 18 |
| Research Status | Pre-clinical | Clinical |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
Pemvidutide Benefits
- ✓appetite suppression
- ✓body-weight reduction
- ✓improved liver-fat markers
- ✓better glycemic control
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
Pemvidutide Dosing
once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
Pemvidutide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠diarrhea
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
Pemvidutide
Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.